Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

999 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of Uveitis Following Initiation of Prostaglandin Analogs Versus Other Glaucoma Medications: A Study from the SOURCE Repository.
Chauhan MZ, Elhusseiny AM, Marwah S, Sallam AB, Stein JD, Kishor KS; SOURCE Consortium; Amin S, Edwards PA, Srikumaran D, Woreta F, Schultz JS, Shrivastava A, Ahmad B, Pasquale L, Bryar PJ, French DD, Hribar M, Thomas M, Vanderbeek BL, Pershing S, Wang SY, Deiner M, Sun C, Patnaik J, Subramanian P, Munir S, Munir W, Stein JD, De Lott L, Ramachandran R, Feldman R, Stagg BC, Wirostko B, McMillian B, Sheybani A, Sarrapour S, Harris-Nwanyanwu K. Chauhan MZ, et al. Among authors: ahmad b. Ophthalmol Glaucoma. 2024 Nov 12:S2589-4196(24)00188-1. doi: 10.1016/j.ogla.2024.10.010. Online ahead of print. Ophthalmol Glaucoma. 2024. PMID: 39542214
Race, Social Determinants of Health, and the Quality of Diabetic Eye Care.
Chaudhury AS, Ige M, Marwah S, Zhou X, Andrews CA, Kanwar K, Evans CT, Kho AN, Stein JD, Bryar PJ, French DD; Sight Outcomes Research Collaborative (SOURCE) Consortium. Chaudhury AS, et al. JAMA Ophthalmol. 2024 Oct 1;142(10):961-970. doi: 10.1001/jamaophthalmol.2024.3528. JAMA Ophthalmol. 2024. PMID: 39264618
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC; Diabetic Retinopathy Clinical Research Network. Jampol LM, et al. Ophthalmology. 2018 Jul;125(7):1054-1063. doi: 10.1016/j.ophtha.2018.01.019. Epub 2018 Mar 7. Ophthalmology. 2018. PMID: 29525602 Free PMC article. Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
999 results